Skip to main content
Premium Trial:

Request an Annual Quote

Special Data Needs Special Treatment

At his Genetic Future blog, Daniel MacArthur gives his two cents on a recent perspective article in Nature Reviews Genetics that discusses the ethical challenges of whole genome sequencing. MacArthur dissects the possible difficulties of getting the right data into the hands of consumers. One of the biggest challenges, he says, is a cost-effective way to give people their sequence with meaningful annotation.  He concludes, "If researchers can't afford to provide the annotation themselves, they should at least return the data in a standardised format that makes it easy for participants to get that annotation from other sources." Clinical follow-up and integrating the data with updated medical and genomic information are also potential challenges.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.